RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases

Abstract

Modifying the t-CS by replacing disease-free interval, number of metastases, and CEA level with RAS mutation status produced an m-CS that outperformed the t-CS. The m-CS is therefore a simple validated tool that predicts survival after resection of CLM.